This company listing is no longer active
Elliptic Laboratories Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Elliptic Laboratories's earnings have been declining at an average annual rate of -2.7%, while the Software industry saw earnings growing at 17.8% annually. Revenues have been growing at an average rate of 30.4% per year.
Información clave
-2.7%
Tasa de crecimiento de los beneficios
4.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Software | 15.7% |
| Tasa de crecimiento de los ingresos | 30.4% |
| Rentabilidad financiera | -10.7% |
| Margen neto | -66.4% |
| Próxima actualización de resultados | 13 Jul 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Elliptic Laboratories. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 23 | 51 | -34 | 1 | 0 |
| 31 Dec 22 | 52 | -33 | 1 | 0 |
| 30 Sep 22 | 77 | -10 | 1 | 0 |
| 30 Jun 22 | 63 | -18 | 1 | 0 |
| 31 Mar 22 | 58 | -17 | 1 | 0 |
| 31 Dec 21 | 55 | -11 | 1 | 0 |
| 30 Sep 21 | 44 | -5 | 1 | 0 |
| 30 Jun 21 | 34 | -9 | 1 | 0 |
| 31 Mar 21 | 32 | -10 | 1 | 0 |
| 31 Dec 20 | 30 | -13 | 1 | 0 |
| 30 Sep 20 | 23 | -24 | 1 | 0 |
| 30 Jun 20 | 29 | -20 | 1 | 0 |
| 31 Mar 20 | 32 | -19 | 1 | 0 |
| 31 Dec 19 | 38 | -13 | 1 | 0 |
| 31 Dec 18 | 42 | -28 | 2 | 0 |
| 31 Dec 17 | 11 | -34 | 3 | 0 |
Ingresos de calidad: ELABSO is currently unprofitable.
Margen de beneficios creciente: ELABSO is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ELABSO is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.
Acelerando crecimiento: Unable to compare ELABSO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: ELABSO is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (13.7%).
Rentabilidad financiera
Alta ROE: ELABSO has a negative Return on Equity (-10.7%), as it is currently unprofitable.